Thirumalai Chemicals Limited (BOM:500412)
India · Delayed Price · Currency is INR 172.35
+4.75 (2.83%)
At close: Jul 27, 2026
Thirumalai Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 17,355 | 20,495 | 20,831 | 21,322 | 19,982 | |
Revenue Growth | -15.32% | -1.61% | -2.30% | 6.71% | 84.04% |
Cost of Revenue | 14,018 | 16,303 | 17,024 | 15,726 | 12,259 |
Gross Profit | 3,337 | 4,192 | 3,807 | 5,596 | 7,723 |
Selling, General & Admin | 972.3 | 958.5 | 835.2 | 824 | 765.3 |
Other Operating Expenses | 2,552 | 2,708 | 2,398 | 2,903 | 2,515 |
Operating Expenses | 4,408 | 4,278 | 3,865 | 4,284 | 3,847 |
Operating Income | -1,070 | -85.9 | -57.7 | 1,313 | 3,877 |
Interest Expense | -805.6 | -444.8 | -358.9 | -262 | -169.1 |
Interest & Investment Income | 73 | 101.5 | 178.7 | 198.9 | 84.8 |
Currency Exchange Gain (Loss) | -113.2 | 24.3 | -54.8 | 78.7 | -11.9 |
Other Non Operating Income (Expenses) | -81.5 | -42.2 | -56.5 | -46.9 | -27.6 |
EBT Excluding Unusual Items | -1,998 | -447.1 | -349.2 | 1,281 | 3,753 |
Gain (Loss) on Sale of Investments | 3.4 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0.9 | 14.9 | 0.5 | 3.3 | - |
Other Unusual Items | -24.8 | 4.5 | - | - | - |
Pretax Income | -2,018 | -408.5 | -345.5 | 1,294 | 3,754 |
Income Tax Expense | -338.8 | 52.5 | 42.4 | 395.8 | 941.4 |
Net Income | -1,679 | -461 | -387.9 | 898.3 | 2,812 |
Net Income to Common | -1,679 | -461 | -387.9 | 898.3 | 2,812 |
Net Income Growth | - | - | - | -68.06% | 138.96% |
Shares Outstanding (Basic) | 113 | 102 | 102 | 102 | 102 |
Shares Outstanding (Diluted) | 113 | 102 | 102 | 102 | 102 |
Shares Change | 9.99% | - | - | - | - |
EPS (Basic) | -14.91 | -4.50 | -3.79 | 8.77 | 27.47 |
EPS (Diluted) | -14.91 | -4.50 | -3.79 | 8.77 | 27.47 |
EPS Growth | - | - | - | -68.06% | 138.96% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -7,300 | -6,788 | -5,737 | -3,086 | 3,287 |
Free Cash Flow Per Share | -64.82 | -66.30 | -56.03 | -30.14 | 32.10 |
Dividend Per Share | - | - | 1.000 | 1.500 | 2.500 |
Dividend Growth | - | - | -33.33% | -40.00% | 13.64% |
Gross Margin | 19.23% | 20.45% | 18.28% | 26.25% | 38.65% |
Operating Margin | -6.17% | -0.42% | -0.28% | 6.16% | 19.40% |
Profit Margin | -9.68% | -2.25% | -1.86% | 4.21% | 14.07% |
Free Cash Flow Margin | -42.06% | -33.12% | -27.54% | -14.47% | 16.45% |
EBITDA | -228.7 | 466.9 | 507.3 | 1,826 | 4,414 |
EBITDA Margin | -1.32% | 2.28% | 2.44% | 8.56% | 22.09% |
D&A For EBITDA | 841.5 | 552.8 | 565 | 512.8 | 537.9 |
EBIT | -1,070 | -85.9 | -57.7 | 1,313 | 3,877 |
EBIT Margin | -6.17% | -0.42% | -0.28% | 6.16% | 19.40% |
Effective Tax Rate | - | - | - | 30.59% | 25.08% |
Revenue as Reported | 17,542 | 20,701 | 21,025 | 21,624 | 20,098 |